MMT Funds

Venture Capital Tel Aviv-Yafo, Israel Est. 1998
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$3.0M
total disclosed, rounds participated
Stages
Pre-Seed, Seed

About

MMT Funds is focused on investing in companies developing advanced materials in the fields of nanotechnology, polymer technologies, biomaterials, energy and environmental technologies, industrial chemistry, and novel crystals, with a special focus on Israeli and Israel-related companies (60-70%). MMT focuses on companies with applications in the life science, microelectronics and semiconductors, and medical device spaces. MMT Fund I, established in 1998, was capitalized at $11 million and is fully invested in nine portfolio companies. MMT Fund II, established in 2000, was capitalized at $40 million and is currently invested in 14 portfolio companies, three of which are follow-on investments to MMT I. In addition to having a material science innovation, the companies MMT invests in have to cater to large, high-growth markets.

Portfolio · 1

Enzymotec
Lipid-based Biofunctional Ingredients and Products
2 rounds $3.0M committed Latest: 2001-06

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is MMT Funds' primary investment focus?
MMT Funds focuses on investing in companies developing advanced materials in nanotechnology, polymer technologies, biomaterials, energy and environmental technologies, industrial chemistry, and novel crystals. They have a special focus on Israeli and Israel-related companies.
Which sectors does MMT Funds prioritize for applications?
MMT Funds prioritizes companies with applications in the life science, microelectronics and semiconductors, and medical device spaces.
When was MMT Funds established?
MMT Funds was founded in 1998.
What is the status of MMT Fund I?
MMT Fund I, established in 1998 with $11 million, is fully invested in nine portfolio companies.
What is the status of MMT Fund II?
MMT Fund II, established in 2000 with $40 million, is currently invested in 14 portfolio companies, three of which are follow-on investments from MMT I.
Can you name a notable exit for MMT Funds?
MMT Funds had an exit with Enzymotec, which went public on NASDAQ in September 2013 after raising $63.5M in capital.
Who are the Senior Partners at MMT Funds?
The Senior Partners at MMT Funds are Zwi Vromen and Oren Gafri.
What investment stages does MMT Funds typically engage in?
MMT Funds typically invests in Pre-Seed and Seed stage companies.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded1998